Page last updated: 2024-08-24

colestipol and probucol

colestipol has been researched along with probucol in 35 studies

Research

Studies (35)

Timeframe	Studies, this research(%)	All Research%
pre-1990	28 (80.00)	18.7374
1990's	7 (20.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Martz, BL	1
Fleischmajer, R	1
D'Amico, G; Gentile, MG	1
Kłosiewicz-Latoszek, L; Szostak, WB	1
Eisenberg, JM; Glick, H; Jacobson, TA; Kinosian, B; Koffer, H; Schulman, KA; Willian, MK	1
Helve, E; Karjalainen, K; Ojala, JP; Tarkkanen, A; Tikkanen, MJ	1
Beltz, WF; Juliano, J; Kelly, N; Lester, P; Simmons, D; Steinberg, D; Weinreb, R; Witztum, JL; Young, SG	1
Dereviacki, BE; Forti, N; Giannini, SD	1
Hunninghake, DB	1
Naito, HK	1
Davignon, J	1
Blum, CB; Levy, RI	1
Nikkilä, EA; Tikkanen, MJ	1
Havel, RJ; Kane, JP	1
Gotto, AM; Jones, PH; Scott, LW	1
Chernoff, SB; Dujovne, CA; Krehbiel, P	1
Kostis, JB; Kuo, PT; Moreyra, AE; Wilson, AC	1
Appel, GB; Blum, C; Gelfand, J; Valeri, A	1
Bilheimer, DW	1
Levy, RI; Schaefer, EJ	1
Chernoff, SB; Decoursey, S; Dujovne, CA; Garty, M; Jackson, B; Krehbiel, P; Pitterman, A	1
Chernoff, SB; DeCoursey, S; Dujovne, CA; Jackson, B; Krehbiel, P; Taylor, H	1
Nash, DT	1
Glueck, CJ	1
Kane, JP; Malloy, MJ	1
Azarnoff, DL; Saunders, RN	1
Mordasini, R; Oster, P; Riesen, W; Riva, G	1
Basich, P; Schonfeld, G; Witztum, J	1
Samuel, P	1
Farmer, JA; Gotto, AM	1

Reviews

10 review(s) available for colestipol and probucol

Article	Year
Reducing high blood cholesterol level with drugs. Cost-effectiveness of pharmacologic management. JAMA, 1990, Dec-19, Volume: 264, Issue:23 Topics: Anticholesteremic Agents; Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Cost-Benefit Analysis; Drug Therapy, Combination; Gemfibrozil; Humans; Hypercholesterolemia; Lovastatin; Niacin; Probucol; Sensitivity and Specificity	1990
[The value of chemotherapeutic intervention on primary hyperlipidemias in the prevention of coronary arteriosclerosis]. Arquivos brasileiros de cardiologia, 1988, Volume: 51, Issue:1 Topics: Adult; Cholesterol; Clinical Trials as Topic; Colestipol; Coronary Artery Disease; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins, LDL; Male; Middle Aged; Probucol	1988
Reducing cardiac deaths with hypolipidemic drugs. Postgraduate medicine, 1987, Nov-01, Volume: 82, Issue:6 Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Coronary Disease; Feeding Behavior; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins, LDL; Niacin; Patient Education as Topic; Pentanoic Acids; Probucol	1987
Treatment of hypercholesterolemia. Annual review of medicine, 1986, Volume: 37 Topics: Animals; Cholestyramine Resin; Clofibrate; Colestipol; Cricetinae; Dogs; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Mice; Middle Aged; Neomycin; Niacin; Pentanoic Acids; Pregnancy; Probucol; Rats	1986
The diagnosis and management of hyperlipidemia. Disease-a-month : DM, 1986, Volume: 32, Issue:5 Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dietary Fats; Gemfibrozil; Humans; Hyperlipidemia, Familial Combined; Hyperlipidemias; Hyperlipoproteinemia Type I; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Lipoproteins; Lipoproteins, LDL; Neomycin; Niacin; Pentanoic Acids; Probucol; Receptors, LDL; Triglycerides	1986
Pathogenesis and management of lipoprotein disorders. The New England journal of medicine, 1985, May-16, Volume: 312, Issue:20 Topics: Abetalipoproteinemia; Adolescent; Adult; Aged; Child; Child, Preschool; Cholestyramine Resin; Chylomicrons; Colestipol; Dietary Fats; Female; Gemfibrozil; Humans; Hyperlipoproteinemia Type I; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Hyperlipoproteinemias; Hypobetalipoproteinemias; Hypolipoproteinemias; Infant; Infant, Newborn; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Niacin; Pentanoic Acids; Probucol; Tangier Disease	1985
Colestipol and probucol: treatment of primary and familial hypercholesterolemia and amelioration of atherosclerosis. Annals of internal medicine, 1982, Volume: 96, Issue:4 Topics: Arteriosclerosis; Cholesterol; Colestipol; Drug Therapy, Combination; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Niacin; Nicotinic Acids; Phenols; Polyamines; Probucol	1982
Treatment of hypercholesterolemia. The Medical clinics of North America, 1982, Volume: 66, Issue:2 Topics: Cholestyramine Resin; Colestipol; Drug Therapy, Combination; Heterozygote; Homozygote; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Neomycin; Niacin; Nicotinic Acids; Probucol; Sitosterols; Thyroxine	1982
Current status of drugs used to treat hyperlipoproteinemias. Drug therapeutics, 1982 Topics: Aminosalicylic Acid; Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Enzyme Induction; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Neomycin; Niacin; Nicotinic Acids; Probucol; Sitosterols	1982
Antihyperlipidaemic agents. Drug interactions of clinical significance. Drug safety, 1994, Volume: 11, Issue:5 Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibric Acid; Colestipol; Drug Interactions; Fibric Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Niacin; Probucol	1994

Trials

10 trial(s) available for colestipol and probucol

Article	Year
Pharmacological and dietary treatment of lipid abnormalities in nephrotic patients. Kidney international. Supplement, 1991, Volume: 31 Topics: Cholestyramine Resin; Colestipol; Food, Formulated; Gemfibrozil; Humans; Hyperlipidemias; Lipids; Lovastatin; Nephrotic Syndrome; Probucol	1991
Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride. Circulation, 1989, Volume: 79, Issue:1 Topics: Cholesterol; Clinical Trials as Topic; Colestipol; Drug Interactions; Drug Therapy, Combination; Humans; Hyperlipoproteinemia Type II; Lipoproteins, HDL; Lipoproteins, LDL; Lovastatin; Phenols; Polyamines; Probucol; Prospective Studies; Triglycerides; Xanthomatosis	1989
[The value of chemotherapeutic intervention on primary hyperlipidemias in the prevention of coronary arteriosclerosis]. Arquivos brasileiros de cardiologia, 1988, Volume: 51, Issue:1 Topics: Adult; Cholesterol; Clinical Trials as Topic; Colestipol; Coronary Artery Disease; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins, LDL; Male; Middle Aged; Probucol	1988
Controlled studies of the efficacy and safety of combined probucol-colestipol therapy. The American journal of cardiology, 1986, Jun-27, Volume: 57, Issue:16 Topics: Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Colestipol; Double-Blind Method; Drug Therapy, Combination; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Phenols; Polyamines; Probucol; Prospective Studies; Time Factors	1986
Effects of combined probucol-colestipol treatment for familial hypercholesterolemia and coronary artery disease. The American journal of cardiology, 1986, Jun-27, Volume: 57, Issue:16 Topics: Adult; Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Colestipol; Combined Modality Therapy; Coronary Disease; Drug Therapy, Combination; Female; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Phenols; Polyamines; Probucol; Triglycerides	1986
Treatment of the hyperlipidemia of the nephrotic syndrome: a controlled trial. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1986, Volume: 8, Issue:6 Topics: Adult; Aged; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Colestipol; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Nephrotic Syndrome; Phenols; Polyamines; Probucol	1986
Probucol with colestipol in the treatment of hypercholesterolemia. Annals of internal medicine, 1984, Volume: 100, Issue:4 Topics: Adult; Cholesterol; Clinical Trials as Topic; Colestipol; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hyperlipoproteinemia Type II; Lipoproteins; Lipoproteins, HDL; Male; Middle Aged; Phenols; Polyamines; Probucol	1984
Low-dose colestipol plus probucol for hypercholesterolemia. The American journal of cardiology, 1984, Jun-01, Volume: 53, Issue:11 Topics: Adult; Cholesterol; Clinical Trials as Topic; Colestipol; Constipation; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Lipoproteins; Lipoproteins, LDL; Male; Middle Aged; Phenols; Polyamines; Probucol	1984
Current status of drugs used to treat hyperlipoproteinemias. Drug therapeutics, 1982 Topics: Aminosalicylic Acid; Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Enzyme Induction; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Neomycin; Niacin; Nicotinic Acids; Probucol; Sitosterols	1982
[Behavior of high-density lipoproteins in drug lipid-lowering treatment]. Schweizerische medizinische Wochenschrift, 1982, Jan-16, Volume: 112, Issue:3 Topics: Adult; Apoproteins; Bezafibrate; Cholesterol; Cholesterol, HDL; Clofibric Acid; Colestipol; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipids; Lipoproteins, HDL; Male; Middle Aged; Probucol	1982

Other Studies

17 other study(ies) available for colestipol and probucol

Article	Year
Drug management of hypercholesterolemia. American heart journal, 1979, Volume: 97, Issue:3 Topics: Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Humans; Hypercholesterolemia; Nicotinic Acids; Probucol; Sitosterols	1979
Hypolipidemic drugs. American family physician, 1978, Volume: 17, Issue:2 Topics: Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Humans; Hyperlipidemias; Lipoproteins; Nicotinic Acids; Probucol	1978
Choice of cholesterol-lowering drugs. The Medical letter on drugs and therapeutics, 1991, Jan-11, Volume: 33, Issue:835 Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Fish Oils; Gemfibrozil; Humans; Lovastatin; Neomycin; Niacin; Probucol	1991
Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia. European journal of clinical pharmacology, 1991, Volume: 40, Issue:1 Topics: Adult; Aged; Bezafibrate; Cholesterol; Clofibrate; Clofibric Acid; Colestipol; Female; Fenofibrate; Gemfibrozil; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Probucol	1991
Long-term maintenance of therapeutic response to lovastatin in patients with familial and non-familial hypercholesterolemia: a 3-year follow-up. Atherosclerosis, 1990, Volume: 82, Issue:1-2 Topics: Adult; Aged; Cholesterol, LDL; Colestipol; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipids; Lipoproteins; Lovastatin; Male; Middle Aged; Polyamines; Probucol; Triglycerides	1990
Current and new therapy for hypercholesterolemia. The Journal of the American Osteopathic Association, 1988, Volume: 88, Issue:7 Topics: Anticholesteremic Agents; Colestipol; Gemfibrozil; Humans; Hypercholesterolemia; Lovastatin; Niacin; Probucol	1988
Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel. Archives of internal medicine, 1988, Volume: 148, Issue:1 Topics: Adult; Aged; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Coronary Disease; Dietary Fats; Female; Gemfibrozil; Humans; Hydroxymethylglutaryl CoA Reductases; Hypercholesterolemia; Male; Middle Aged; Niacin; Patient Compliance; Pentanoic Acids; Probucol; Risk Factors	1988
Medical management of hyperlipidemia and the role of probucol. The American journal of cardiology, 1986, Jun-27, Volume: 57, Issue:16 Topics: Adult; Arteriosclerosis; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Female; Gemfibrozil; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Middle Aged; Niacin; Pentanoic Acids; Phenols; Probucol; Risk	1986
Rational drug therapy of the hyperlipoproteinemias, Part II. Rational drug therapy, 1986, Volume: 20, Issue:10 Topics: Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Female; Fish Oils; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Neomycin; Niacin; Pentanoic Acids; Probucol	1986
Current pharmacologic treatment of elevated serum cholesterol. Circulation, 1987, Volume: 76, Issue:3 Topics: Adult; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Drug Tolerance; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Naphthalenes; Neomycin; Niacin; Pentanoic Acids; Probucol; Simvastatin; Triglycerides	1987
Lipoprotein fractions and receptors: a role for probucol? The American journal of cardiology, 1986, Jun-27, Volume: 57, Issue:16 Topics: Anticholesteremic Agents; Biological Transport; Cholesterol; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Colestipol; Humans; Hydroxymethylglutaryl CoA Reductases; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins; Lipoproteins, HDL; Lipoproteins, IDL; Lipoproteins, VLDL; Lovastatin; Naphthalenes; Phenols; Probucol; Receptors, LDL	1986
Lipid-lowering drugs. The Medical letter on drugs and therapeutics, 1985, Aug-30, Volume: 27, Issue:695 Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Gemfibrozil; Humans; Hypolipidemic Agents; Lipoproteins; Neomycin; Niacin; Pentanoic Acids; Probucol; Triglycerides	1985
Gemfibrozil in combination with other drugs for severe hyperlipidemia. Preliminary study comprising four cases. Postgraduate medicine, 1983, Volume: 73, Issue:4 Topics: Adult; Cholesterol; Cholestyramine Resin; Colestipol; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hyperlipidemias; Lipoproteins, HDL; Male; Middle Aged; Niacin; Pentanoic Acids; Probucol; Triglycerides; Valerates	1983
Probucol further lowers the serum cholesterol of colestipol-treated patients with hypercholesterolemia. Artery, 1982, Volume: 10, Issue:2 Topics: Adult; Aged; Apoproteins; Cholesterol; Colestipol; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Lipoproteins; Male; Middle Aged; Phenols; Polyamines; Probucol; Triglycerides	1982
Lipid-lowering drugs. The Medical letter on drugs and therapeutics, 1980, Aug-08, Volume: 22, Issue:16 Topics: Cholestyramine Resin; Clofibrate; Colestipol; Humans; Hypolipidemic Agents; Neomycin; Nicotinic Acids; Probucol	1980
Drug treatment of hyperlipidemia. American heart journal, 1980, Volume: 100, Issue:4 Topics: Adolescent; Adult; Child; Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Humans; Hyperlipidemias; Middle Aged; Neomycin; Nicotinic Acids; Probucol	1980
Choice of cholesterol-lowering drugs. The Medical letter on drugs and therapeutics, 1993, Mar-05, Volume: 35, Issue:891 Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Fish Oils; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Niacin; Probucol	1993